Abbott India (BOM:500488) Asset Turnover: 0.26 (As of Mar. 2026)


BOM:500488 Abbott India Ltd BOM:500488
88 GF Score
Price ₹26,232.80
GF Value ₹32,373.98
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott India Asset Turnover?

Abbott India BOM:500488 -1.79% 88 Asset Turnover is 0.26 as of Mar. 2026. GuruFocus rates BOM:500488 with a GF Score™ of 88/100 and a GF Value™ of ₹32,373.98 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Abbott India's Revenue for the three months ended in Mar. 2026 was ₹17,095 Mil. Abbott India's Total Assets for the quarter that ended in Mar. 2026 was ₹65,019 Mil. Therefore, Abbott India's Asset Turnover for the quarter that ended in Mar. 2026 was 0.26.

Asset Turnover is linked to ROE % through Du Pont Formula. Abbott India's annualized ROE % for the quarter that ended in Mar. 2026 was 33.09%. It is also linked to ROA % through Du Pont Formula. Abbott India's annualized ROA % for the quarter that ended in Mar. 2026 was 24.30%.


Abbott India  (BOM:500488) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Abbott India's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=15797.2/47741.9
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(15797.2 / 68380.4)*(68380.4 / 65019.3)*(65019.3/ 47741.9)
=Net Margin %*Asset Turnover*Equity Multiplier
=23.1 %*1.0517*1.3619
=ROA %*Equity Multiplier
=24.30 %*1.3619
=33.09 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Abbott India's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=15797.2/65019.3
=(Net Income / Revenue)*(Revenue / Total Assets)
=(15797.2 / 68380.4)*(68380.4 / 65019.3)
=Net Margin %*Asset Turnover
=23.1 %*1.0517
=24.30 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Abbott India Asset Turnover Related Terms


Abbott India Asset Turnover Historical Data

* Premium members only.

The historical data trend for Abbott India's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott India Asset Turnover Chart

Abbott India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 1.22 1.20 1.15 1.12

Abbott India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.29 0.31 0.30 0.26

BOM:500488 vs ZTS, UTHR: Asset Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott India's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India Asset Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Abbott India's Asset Turnover falls into.


BOM:500488
88GF Score
Abbott India Ltd BOM:500488
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott India Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Abbott India's Asset Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=69290.5/( (59173.1+65019.3)/ 2 )
=69290.5/62096.2
=1.12

Abbott India's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=17095.1/( (0+65019.3)/ 1 )
=17095.1/65019.3
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.26 mean?
Abbott India (BOM:500488) has a Asset Turnover of 0.26 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Abbott India and its competitors.
Is Abbott India's Asset Turnover too high?
Abbott India's current Asset Turnover is 0.26. Overall, Abbott India has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott India's Asset Turnover compare to ZTS and UTHR?
Abbott India's Asset Turnover of 0.26 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Drug Manufacturers company?
A good Asset Turnover depends on the Drug Manufacturers industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Abbott India and its competitors. Abbott India's current Asset Turnover is 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott India stock overvalued right now?
Based on GuruFocus' analysis, Abbott India (BOM:500488) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹32,373.98, compared to a current price of ₹26,232.80 — trading 19% below its estimated fair value. The current Asset Turnover is 0.26. Abbott India's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Abbott India (BOM:500488), the current Asset Turnover is 0.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott India (BOM:500488) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott India stock appears to be undervalued. The current stock price of ₹26,232.80 is trading 19% below its estimated GF Value™ of ₹32,373.98. GuruFocus considers Abbott India to be Modestly Undervalued.

Key valuation signals for BOM:500488:

  • Asset Turnover: 0.26
  • GF Value™: ₹32,373.98 vs. price of ₹26,232.80 (19% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the BOM:500488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott India Business Description

Other Exchanges ABBOTINDIA:India
Address Plot C-68, G Block, 16th Floor, Godrej BKC, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
88GF Score

Get the complete analysis for BOM:500488

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹26,232.80
Price
₹32,373.98
GF Value